IRIS
OTTANA', Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.933
NA - Nord America 6.445
AS - Asia 3.859
SA - Sud America 1.553
AF - Africa 101
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.903
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.331
RU - Federazione Russa 4.036
SG - Singapore 1.681
BR - Brasile 1.334
CN - Cina 1.074
IE - Irlanda 1.051
SE - Svezia 954
HK - Hong Kong 436
DE - Germania 403
UA - Ucraina 395
IT - Italia 264
FI - Finlandia 221
FR - Francia 219
VN - Vietnam 196
GB - Regno Unito 161
IN - India 102
PL - Polonia 77
AR - Argentina 61
BD - Bangladesh 47
CA - Canada 47
IQ - Iraq 43
EC - Ecuador 41
MX - Messico 39
TR - Turchia 36
JP - Giappone 32
CO - Colombia 30
AT - Austria 29
MA - Marocco 28
UZ - Uzbekistan 27
PK - Pakistan 26
VE - Venezuela 26
IR - Iran 21
NL - Olanda 21
ZA - Sudafrica 21
ID - Indonesia 20
BE - Belgio 17
CL - Cile 16
CZ - Repubblica Ceca 15
KE - Kenya 15
PY - Paraguay 13
BO - Bolivia 11
KR - Corea 11
UY - Uruguay 11
JO - Giordania 10
SA - Arabia Saudita 10
AZ - Azerbaigian 9
DZ - Algeria 9
IL - Israele 9
PE - Perù 9
ES - Italia 8
JM - Giamaica 8
LT - Lituania 8
RS - Serbia 8
AU - Australia 7
EG - Egitto 7
GR - Grecia 7
MY - Malesia 7
NP - Nepal 7
TN - Tunisia 7
CH - Svizzera 6
KZ - Kazakistan 6
LV - Lettonia 6
NO - Norvegia 6
OM - Oman 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
PT - Portogallo 5
CR - Costa Rica 4
LB - Libano 4
TT - Trinidad e Tobago 4
AL - Albania 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LK - Sri Lanka 3
PA - Panama 3
RO - Romania 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
EU - Europa 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
MM - Myanmar 2
PS - Palestinian Territory 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BT - Bhutan 1
BW - Botswana 1
CU - Cuba 1
EE - Estonia 1
GE - Georgia 1
Totale 19.889
Salva come PNG Salva come JPEG
Città #
Moscow 1.259
Dublin 1.050
Singapore 893
Jacksonville 783
Ashburn 718
Chandler 712
Dallas 696
Nyköping 594
Hong Kong 435
Dearborn 434
Beijing 371
The Dalles 191
Princeton 181
San Jose 177
Medford 176
Cambridge 172
Lauterbourg 154
Los Angeles 148
Des Moines 97
Ann Arbor 94
Boardman 93
Buffalo 89
São Paulo 85
Ho Chi Minh City 84
Munich 83
Warsaw 72
New York 67
Messina 64
San Mateo 61
Tianjin 54
Jinan 49
Belo Horizonte 46
Wilmington 46
Guangzhou 44
Turku 39
Rio de Janeiro 38
Woodbridge 33
Chennai 26
Hanoi 26
Orem 26
Vienna 26
Lancaster 25
Curitiba 24
Redondo Beach 24
Shenyang 24
Tokyo 24
Haikou 23
Nanjing 23
Frankfurt am Main 22
Santa Clara 22
Tashkent 22
Seattle 21
Shanghai 21
Brasília 20
Salvador 19
Baghdad 18
Phoenix 18
Brussels 17
Denver 17
Atlanta 16
Campinas 16
Hebei 16
Houston 16
St Petersburg 16
Ardabil 15
Milan 15
Shenzhen 15
Chicago 13
Johannesburg 13
London 13
Montreal 13
Ningbo 13
Quito 13
Stockholm 13
Brooklyn 12
Fuzhou 12
Taiyuan 12
Taizhou 12
Washington 12
Boston 11
Dhaka 11
Düsseldorf 11
Hefei 11
Manchester 11
Nanchang 11
Porto Alegre 11
Pune 11
San Francisco 11
Francofonte 10
Istanbul 10
Manaus 10
Mumbai 10
Nairobi 10
Pelotas 10
Sorocaba 10
Windsor 10
Augusta 9
Bremen 9
Chemnitz 9
Contagem 9
Totale 11.361
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 244
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 199
Synthesis of tertiary alkyl-substituted acetylenes by electrophilic addition to silylacetylenes 198
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 185
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 184
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 182
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 181
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 181
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 180
3,3'-bi(1,3-thiazolidin-4-one) system. VIII. 3,3'-(1,2-ethanediyl) derivatives and corresponding 1,1'-disulfones: Synthesis, stereochemistry and antiinflammatory activity 175
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 174
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 174
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 170
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 170
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 170
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 169
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 169
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 166
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 166
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 163
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 163
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 162
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 162
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 160
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 157
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 157
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 156
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 155
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 155
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 155
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 155
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 154
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 151
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 150
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 149
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 147
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 147
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 146
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 145
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 145
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 145
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 144
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 143
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 142
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 139
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 139
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 137
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 136
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 136
HALOGENATED ISONIAZID DERIVATIVES .2. UNUSUAL SYNTHESIS OF DELTA(2)-1,3,4-OXADIAZOLINE DERIVATIVES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 135
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 135
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 135
(5-Arylidene-2-thioxo-4-oxothiazolidin-3-yl)acetic acids endowed with chondroprotective and matrix metalloproteinase inhibitory activities 133
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 131
Electronegativity of zeolites in relation to catalytic activity in the conversion of methanol to hydrocarbons 131
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells 131
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 130
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 125
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 125
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 125
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 124
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 123
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 123
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 123
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 122
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 121
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 120
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 118
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 118
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 117
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 116
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 116
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 116
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 115
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 114
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 114
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 113
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 112
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 108
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 108
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 107
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 107
Sintesi di idrocarburi da metanolo su zeoliti commerciali. Relazione fra attività catalitica e acidità 105
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 104
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 104
Utilization of zeolites in agriculture. Part II: Influence in spinach growing. 104
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 104
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 103
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 103
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 102
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 102
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 102
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 102
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 102
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 102
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 101
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 101
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 100
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 99
HALOGENATED ISONIAZID DERIVATIVES .4. 1-METHYLIDENEAMINO-2- TRIFLUOROMETHYLAZIRIDINES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 99
Totale 13.762
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.083
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021268 0 0 0 0 0 0 0 0 0 117 110 41
2021/20221.073 6 136 34 42 61 5 72 43 13 106 168 387
2022/20232.957 234 285 143 263 198 312 68 129 1.219 13 64 29
2023/2024514 37 94 75 41 57 96 7 27 0 15 6 59
2024/20253.128 62 25 52 167 140 71 59 712 838 187 234 581
2025/20268.908 389 677 716 795 655 2.142 1.134 1.121 1.020 259 0 0
Totale 19.996